ASTRAZENECA PHARMA IND LT (ASTRAZEN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.[1]

ASTRAZENUpdated 4 Sept 2026, 2:13

Astrazeneca Pharma Ind Lt

Market Cap

₹17,346Cr.

Current Price

₹6,940

High / Low

₹9,850/6,832

Stock P/E

100.0

ROE23.3%
ROCE29.3%
Book Value₹349
Face Value₹2.00
Dividend Yield0.52%

About

AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days305429354037383939433934
Inventory Days157141121229186197198164193140208272
Days Payable203174184257266251221223231121173207
Cash Conversion Cycle-1621-347-39-1715-201627499
Working Capital Days-15-28-36-8-14-16-17-34-18202250
ROCE %-13%4%15%19%27%34%30%16%31%31%33%29%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 4 September 2026 at 2:13


Designed & Shipped by Harshit Bansal